Stay updated with breaking news from Nasdaq Ctic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued research reports about the company. Lake Street Capital lowered CTI BioPharma from a buy rating to a […]
Sectoral Asset Management Inc. raised its holdings in shares of CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) by 1.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 980,300 shares of the biopharmaceutical company’s stock after acquiring an additional 12,000 shares during the quarter. […]
SVB Securities cut shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) from an outperform rating to a market perform rating in a research note issued to investors on Tuesday, The Fly reports. Several other equities research analysts have also recently commented on CTIC. StockNews.com raised CTI BioPharma from a sell rating to a hold rating […]
Stifel Nicolaus lowered shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) from a buy rating to a hold rating in a report published on Monday, The Fly reports. CTIC has been the topic of several other reports. TD Cowen lowered their target price on CTI BioPharma from $10.00 to $8.00 and set an outperform rating […]
SVB Securities cut shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) from an outperform rating to a market perform rating in a research note released on Tuesday morning, The Fly reports. CTIC has been the topic of several other reports. JMP Securities downgraded shares of CTI BioPharma from an outperform rating to a market perform […]